Clin2
NCT04221997Possibly a fitRecruiting

Sertraline study for anxious children and teens

Anxiety Disorders

Treatments studied

Part of Mental health clinical trials.

This trial tests whether sertraline (an anti-anxiety medicine) helps children and teens with generalized, separation, and/or social anxiety disorders. It also includes healthy children/teens for comparison so researchers can better understand safety and symptoms over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
150 people
Ages
8 years to 17 years
Study type
Interventional

Who can take part

  • Age 8–17 at the first visit, with a parent/guardian who can participate
  • You (and your parent/guardian) must be comfortable speaking and reading English
  • If you have anxiety: you must meet specific anxiety diagnoses, confirmed by an interview, and not have a history of mania or obsessive-compulsive disorder (OCD)
  • Your anxiety severity must be above a certain level on a rating form at both Visit 1 and Visit 2
  • You must be willing for a caregiver to help with safety monitoring and follow study medicine visits
  • You must be able to attend all follow-up visits and swallow capsules

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06081348Recruiting· Phase 2
Sertraline vs. placebo for anxiety in kids with developmental disorders

This trial compares sertraline (a common antidepressant) to a placebo (a pill with no medicine) to see which better reduces anxiety in children and teens who also have a neurodevelopmental disorder like autism, ADHD, or Tourette's. The goal is to help you and your child understand if this treatment might offer relief from anxiety.

Calgary, Alberta
NCT00018057Recruiting· Phase 2
Brain study of pediatric anxiety disorders

This study looks at how the brain works in children and adults with anxiety disorders. It uses brain scans (fMRI) and other safe tests to understand anxiety better.

Bethesda, Maryland
NCT04245436Recruiting· Phase 4
Testing antidepressants for teens with anxiety

This trial studies whether an antidepressant can help teens (ages 12–17) with anxiety disorders such as generalized, social, separation, or panic anxiety. It looks at both early and longer-term success of treatment, while monitoring safety closely with a caregiver.

Cincinnati, Ohio
NCT04623099Recruiting· Phase 4
Personalized escitalopram dosing for anxious teens

This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.

Cincinnati, Ohio
NCT07192367Recruiting· Phase 4
Virtual reality vs. medication for social anxiety in teens

This trial tests whether virtual reality therapy works as well as a common medication (sertraline) for teenagers with social anxiety disorder. Participants will be assigned to either VR exposure therapy or medication, and the study aims to find out which approach is more effective.

Kocaeli
NCT07645157Recruiting· Phase 2
Sertraline and Probiotics for Teen Depression

This study tests whether combining an antidepressant medication (sertraline) with special bacteria supplements (probiotics) can help treat depression in teenagers ages 12–18. Researchers believe the probiotics may help the medication work better by improving gut health.

Chongqing, Yuzhong

Hear when a new Anxiety Disorders trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.